Table 1.
Phenotype | Cytokines/chemokines | Receptors | Enzymes | Other markers |
---|---|---|---|---|
Surveilling | Low | CXCR2 | Low iNOS | |
CD172a | low ARG1 | |||
CD200R1 | ||||
Low IBA-1 | ||||
Low F4/80 | ||||
M1-profile | IL-6 | MHCII | iNOS | |
IL-1 | C-type lectins | COX1 | ||
IL-12p40 | CAT2 | |||
TNF | CD8 | |||
IFN | F4/80 | |||
IBA-1 | ||||
MARCO | ||||
RAGE | ||||
M2-profile | IL-4 | MHCII | ARG1 | YM-1 |
IL-5 | C-type lectins | Lack of iNOS | FIZZ1 | |
IL-13 | CAT2 | sphk1/2 | SOCS3 | |
IL-10 | MR | |||
TGF | DC-SIGN | |||
CCL-18 | IL-4Rα | |||
IL-1Rα | ||||
CD36 | ||||
CD136 |
ARG1 arginase 1; CAT2, cationic amino-acid transporter 2; CCL-18, chemokine 18; CD172a, receptor for CD47; CD200R1, receptor for CD200; CXCR2, receptor for CXC3-chemokine ligand-1; DC-SIGN, dendritic cell-specific intracellular adhesion molecule 3-grabbing integrin; FIZZ1, found in inflammatory zone; IBA-1, ionized calcium-binding adapter molecule 1; IFN, interferon; IL-1, interleukin 1; IL-1Ra interleukin 1 receptor antagonist; IL-4Rα, interleukin 4 receptor α; IL-5, interleukin 5; IL-6, interleukin 6; IL-10, interleukin 10; IL-12p40, interleukin 12 p40 subunit; IL-13, interleukin 13; iNOS, inducible nitric oxide synthase; MARCO, macrophage receptor with collagenous structure; MHCII, major histocompatibility antigen II; MR, manose receptor; RAGE, receptor for advanced glycation endproducts; SOCS3, suppressor of cytokine signaling 3; sphk, sphingosine kinase; TGF-b, tumor growth factor b; TNF, tumor necrosis factor; YM-1, mouse homolog chitinase 3 like 1 (CHI3L1).